Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Archive Search

Pages

74 results
4:07 PM, Jun 05, 2018  |  BC Extra | Company News

Management tracks: Sarepta, Gilead

said CFO Gary Titus is stepping down. COO Stephen Mullennix will serve as interim CFO. GPCR
2:30 PM, Jan 19, 2018  |  BC Extra | Company News

Management tracks: Shire, Sosei

plc (LSE: SHP, NASDAQ: SHPG) on March 19. The company announced his hiring in November. GPCR
10:03 PM, Dec 18, 2017  |  BC Extra | Company News

Confo, Roche in GPCR deal

granted Roche (SIX:ROG; OTCQX:RHHBY) exclusive, worldwide rights to its small molecule agonists against an undisclosed GPCR
declined to disclose details. Confo's Confobodies mimic the role of the G protein to stabilize GPCRs …
began a separate discovery collaboration with H. Lundbeck A/S (CSE:LUN) centered on two other undisclosed GPCRs …
11:42 AM, May 03, 2017  |  BC Extra | Company News

Sosei invests in MiNA, gets option to acquire

said the deal is consistent with its strategy to identify technologies that could complement its GPCR-targeted …
5:30 PM, Jan 13, 2016  |  BC Extra | Company News

Boehringer, Arena strike CNS deal

granted Boehringer Ingelheim GmbH (Ingelheim, Germany) exclusive, worldwide rights to drug candidates targeting an undisclosed GPCR
7:11 PM, Nov 30, 2015  |  BC Extra | Company News

Pfizer, Heptares strike GPCR deal

that would give the pharma exclusive, worldwide rights to therapeutics targeting up to 10 undisclosed GPCRs …
6:05 PM, Feb 21, 2013  |  BC Extra | Company News

UCB, ConfometRx in GPCR discovery deal

UCB Group (Euronext:UCB) and structural biology company ConfometRx (Santa Clara, Calif.) partnered to research GPCR modulation …
disclose details. ConfometRx is developing structure-based drug discovery technologies for lead identification and optimization for GPCRs …
The technologies include technologies that characterize ligand-induced structural changes and generate GPCR-specific, functional antibodies for target …
6:10 PM, Jan 07, 2013  |  BC Extra | Company News

Heptares, Cubist in GPCR discovery deal

U.K.) and Cubist Pharmaceuticals Inc. (NASDAQ:CBST) partnered to discover and develop compounds against two undisclosed GPCR
6:20 PM, Oct 23, 2012  |  BC Extra | Company News

Domain, Ono in GPCR deal

will use its DTect-All drug discovery platform to design and optimize small molecules targeting undisclosed GPCRs …
research funding and is eligible for milestones, plus royalties. Domain said Ono has selected one GPCR
6:27 PM, Jul 23, 2012  |  BC Extra | Company News

Boehringer to acquire Funxional's somatotaxin portfolio

remaining portfolio includes its GAEL technology to generate libraries of novel small molecules enriched in GPCR

Pages